Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Cancer Cytopathology|May 7, 2016
Prognostic impact of a 3-MicroRNA signature in cytological samples of small cell lung cancerGiuseppe Mancuso, Enrica Bovio, Ottavio Rena, et al.
Journal of Thoracic Disease|January 20, 2025
Use of the anatomical formulae for predicted postoperative (PPO) evaluation overestimates the loss of FEV1 and DLCO after minimally invasive lung resectionsSara Degiovanni, Sara Parini, Guido Baietto, et al.
Diagnostic Cytopathology|July 9, 2015
Frequency of O⁶-methylguanine-DNA methyltransferase promoter methylation in cytological samples from small cell lung cancerUmberto Miglio, Rosanna Mezzapelle, Alessia Paganotti, et al.
The Journal of Thoracic and Cardiovascular Surgery|April 12, 2005
Large-cell neuroendocrine carcinoma of the lung: a clinicopathologic study of eighteen cases and the efficacy of adjuvant treatment with octreotidePier Luigi Filosso, Enrico Ruffini, Alberto Oliaro, et al.
Cancer Cytopathology|May 29, 2020
Comparative analysis of programmed death ligand 1 expression in paired cytologic and histologic specimens of non-small cell lung cancerMatteo Daverio, Filippo Patrucco, Francesco Gavelli, et al.
Pathology|December 4, 2020
Programmed cell death 1 ligand 1 (PD-L1) expression is associated with poor prognosis of malignant pleural mesothelioma patients with good performance statusEltjona Rrapaj, Lorenzo Giacometti, Paolo Spina, et al.
Tumori|February 8, 2014
Non-small cell lung cancer in surgically treated womenOttavio Rena, Fabio Massera, Renzo Boldorini, et al.
Histopathology|January 23, 2018
Expression analysis of HMGB1 in histological samples of malignant pleural mesotheliomaEltjona Rrapaj, Elena Trisolini, Luca Bertero, et al.
Cancers|September 3, 2020
Deep Sequencing Analysis Identified a Specific Subset of Mutations Distinctive of Biphasic Malignant Pleural MesotheliomaFederica Torricelli, Filippo Lococo, Teresa Severina Di Stefano, et al.
Human Pathology|June 25, 2010
World Health Organization classification of thymomas provides significant prognostic information for selected stage III patients: evidence from an international thymoma study groupAlberto M Marchevsky, Ruta Gupta, Caterina Casadio, et al.
Pageof 7